Endocrine Disorders: Evaluation and Management

  • Author: Todd T. Brown, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 11/14/16 (What's New)

Summary

  • Role of antiretroviral switching in the management of HIV-infected patients with diabetes is not clear
  • If deterioration in glucose metabolism appears temporally linked to ART initiation, and other HIV treatment options are available, antiretroviral substitution should be considered
  • Thymidine analogue substitution should be considered because of their toxicity profile

Action required

Keywords: Diabetes, Endocrine Disorders

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.